trending Market Intelligence /marketintelligence/en/news-insights/trending/fjjB3OUAWYlDJt_rkZhZOg2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Medifast Q2 profit falls 9.6% YOY


So, the data lakehouse is now officially a ‘thing’ – what is it and why should you care?


Industry Top Trends 2021: Oil and Gas


Charter, DIRECTV and Comcast rank as the top 'RSN-friendly' MVPDs

Industry Top Trends 2021: Metals and Mining

Medifast Q2 profit falls 9.6% YOY

Medifast Inc. said its normalized net income for the second quarter amounted to 47 cents per share, compared with the S&P Capital IQ consensus estimate of 48 cents per share.

EPS decreased year over year from 48 cents.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was $5.7 million, a decrease of 9.6% from $6.3 million in the prior-year period.

The normalized profit margin dropped to 7.9% from 8.4% in the year-earlier period.

Total revenue decreased year over year to $72.2 million from $74.7 million, and total operating expenses declined on an annual basis to $63.2 million from $64.9 million.

Reported net income declined 11.2% on an annual basis to $5.8 million, or 48 cents per share, from $6.6 million, or 50 cents per share.